936663055	936663055	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
03543874	03543874	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7807520	7807520	CD	B-NP	O
|	|	CC	I-NP	O
2/15/2006	2/15/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
POST	POST	NNP	I-NP	I-protein
OP	OP	NNP	I-NP	I-protein
LOWER	LOWER	NNP	I-NP	I-protein
EXTREMITY	EXTREMITY	NNP	I-NP	I-protein
EDEMA	EDEMA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Unsigned	Unsigned	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/15/2006	2/15/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/28/2007	5/28/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MONTIETH	MONTIETH	NNP	B-NP	O
,	,	,	O	O
LUCIANO	LUCIANO	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
question	question	NN	B-NP	O
incisional	incisional	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
68-year-old	68-year-old	JJ	B-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
underwent	undergo	VBD	B-VP	O
mitral	mitral	JJ	B-NP	O
valvuloplasty	valvuloplasty	NN	I-NP	O
and	and	CC	I-NP	O
CABG	CABG	NN	I-NP	B-protein
on	on	IN	B-PP	O
10/2/06	10/2/06	CD	B-NP	O
,	,	,	O	O
postoperative	postoperative	JJ	B-NP	O
issues	issue	NNS	I-NP	O
included	include	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
1/3/06	1/3/06	CD	B-NP	O
and	and	CC	O	O
now	now	RB	B-VP	O
returns	return	VBZ	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
with	with	IN	B-PP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
swelling	swelling	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
erythema	erythema	NN	B-NP	O
noted	note	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
pole	pole	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
sternal	sternal	JJ	I-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
purulent	purulent	JJ	B-NP	O
drainage	drainage	NN	I-NP	O
from	from	IN	B-PP	O
wound	wound	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
or	or	CC	O	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
recent	recent	JJ	B-NP	O
low-grade	low-grade	JJ	I-NP	O
temperatures	temperature	NNS	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
tonsils	tonsil	NNS	I-NP	O
and	and	CC	I-NP	O
adenoids	adenoid	NNS	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
tubal	tubal	JJ	I-NP	O
ligation	ligation	NN	I-NP	O
and	and	CC	I-NP	O
removal	removal	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
lipoma	lipoma	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Mother	Mother	NNP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
remote	remote	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
quit	quit	NN	B-NP	O
9	9	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Ard	Ard	NNP	I-NP	O
Ont	Ont	NNP	I-NP	O
Esnowi	Esnowi	NNP	I-NP	O
She	She	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
retired	retired	JJ	I-NP	O
clothing	clothing	NN	I-NP	O
company	company	NN	I-NP	O
worker	worker	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Bactrim	Bactrim	JJ	B-NP	O
causing	cause	VBG	I-NP	O
hives	hive	NNS	I-NP	O
and	and	CC	I-NP	O
erythromycin	erythromycin	NN	I-NP	O
causing	cause	VBG	B-VP	O
abdominal	abdominal	JJ	B-NP	O
cramps	cramp	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
25	25	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Valsartan	Valsartan	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
variable	variable	JJ	I-NP	O
dose	dose	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Spironolactone	Spironolactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Simvastatin	Simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Nortriptyline	Nortriptyline	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Fluoxetine	Fluoxetine	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
88	88	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
Height	Height	NNP	B-NP	O
5	5	CD	B-NP	O
feet	foot	NNS	I-NP	O
2	2	CD	B-NP	O
inches	inch	NNS	I-NP	O
tall	tall	JJ	B-ADJP	O
and	and	CC	O	O
weight	weight	NN	B-NP	O
97	97	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	B-protein
98.8	98.8	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
90	90	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
120/72	120/72	CD	I-NP	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
oropharynx	oropharynx	NN	B-NP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Chest	Ch	JJS	B-ADVP	O
with	with	IN	B-PP	O
midline	midline	NN	B-NP	O
incision	incision	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
,	,	,	I-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
stable	stable	JJ	B-NP	O
sternum	sternum	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
clicks	click	NNS	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-ADJP	O
,	,	,	O	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
without	without	IN	B-PP	O
incisions	incision	NNS	B-NP	O
,	,	,	O	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
erythema	erythema	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

Pedal	Pedal	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
are	be	VBP	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Radial	Radial	NNP	B-NP	O
pulses	pulse	VBZ	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neuro	Neuro	RB	B-ADVP	O
,	,	,	O	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
,	,	,	O	O
grossly	grossly	RB	B-NP	O
nonfocal	nonfocal	JJ	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Chemistries	Chemistry	NNS	B-NP	O
include	include	VBP	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
of	of	IN	B-PP	O
132	132	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
0.8	0.8	CD	B-NP	O
and	and	CC	O	O
BNP	BNP	NN	B-NP	O
of	of	IN	B-PP	O
2520	2520	CD	B-NP	O
.	.	.	O	O

Hematology	Hematology	NNP	B-NP	O
includes	include	VBZ	B-VP	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
6.8	6.8	CD	B-NP	O
and	and	CC	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
24.6	24.6	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
4/12/06	4/12/06	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
significant	significant	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
with	with	IN	B-PP	O
probable	probable	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
pulmonary	pulmonary	JJ	B-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
for	for	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
transthoracic	transthoracic	JJ	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
Diuril	Diuril	NNP	B-NP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
for	for	IN	B-PP	O
coverage	coverage	NN	B-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
team	team	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
regimen	regimen	NN	B-NP	O
of	of	IN	B-PP	O
Advair	Advair	NNP	B-NP	O
and	and	CC	O	O
steroid	steroid	JJ	B-NP	O
taper	taper	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
COPD	COPD	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
empirically	empirically	RB	I-VP	O
covered	cover	VBN	I-VP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
diurese	diurese	VB	I-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Step-Down	Step-Down	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
preadmission	preadmission	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
meds	med	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
were	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
required	require	VBD	B-VP	O
ongoing	ongoe	VBG	I-VP	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
to	to	TO	B-VP	O
eventually	eventually	RB	I-VP	O
achieve	achieve	VB	I-VP	O
a	a	DT	B-NP	O
fluid	fluid	JJ	I-NP	O
balance	balance	NN	I-NP	O
of	of	IN	B-PP	O
is	be	VBZ	B-VP	O
negative	negative	JJ	B-NP	O
1	1	CD	I-NP	O
liter	liter	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

With	With	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
postural	postural	JJ	B-NP	O
dizziness	dizziness	NN	I-NP	O
,	,	,	I-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
and	and	CC	I-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
amylase	amylase	NN	B-NP	B-protein
and	and	CC	I-NP	O
lipase	lipase	NN	I-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
noted	note	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

KUB	KUB	NN	B-NP	B-protein
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
small-bowel	small-bowel	JJ	B-NP	O
obstruction	obstruction	NN	I-NP	O
or	or	CC	I-NP	O
perforation	perforation	NN	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
with	with	IN	B-PP	O
stool	stool	NN	B-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
colon	colon	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
bowels	bowel	NNS	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
move	move	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continues	continue	VBZ	B-VP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
both	both	CC	O	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
and	and	CC	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
8	8	CD	I-NP	I-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Zetia	Zetia	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Fluoxetine	Fluoxetine	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Advair	Advair	NNP	B-NP	O
Diskus	Diskus	NNP	I-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
nebulized	nebulize	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	B-protein
60	60	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
30	30	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	I-protein
q.p.m.	q.p.m.	RB	B-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
20	20	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	I-protein
q.a.m.	q.a.m.	RB	B-ADVP	I-protein
8	8	CD	B-NP	I-protein
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
30	30	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Levofloxacin	Levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
24	24	CD	I-NP	O
h.	h.	NN	I-NP	O
x4	x4	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Levothyroxine	Levothyroxine	NN	B-NP	O
88	88	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Toprol-XL	Toprol-XL	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Nortriptyline	Nortriptyline	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
nightly	nightly	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
taper	taper	NN	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	RB	B-NP	O
24	24	CD	I-NP	O
h.	h.	NN	I-NP	O
x3	x3	NN	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	RB	B-NP	O
24	24	CD	I-NP	O
h.	h.	NN	I-NP	O
x3	x3	NN	I-NP	O
doses	dose	NNS	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	RB	B-NP	O
24	24	CD	I-NP	O
h.	h.	NN	I-NP	O
x3	x3	NN	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
then	then	RB	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	RB	B-NP	O
24	24	CD	I-NP	O
h.	h.	NN	I-NP	O
x3	x3	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Simvastatin	Simvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
nightly	nightly	RB	I-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Diovan	Diovan	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
to	to	TO	I-VP	O
maintain	maintain	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
followup	followup	NN	B-NP	O
appointments	appointment	NNS	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Schwarzkopf	Schwarzkopf	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Carlough	Carlough	NNP	I-NP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
to	to	TO	I-NP	O
six	six	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	B-protein
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
her	her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
,	,	,	I-NP	O
weight	weight	NN	I-NP	O
and	and	CC	I-NP	O
wounds	wound	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
INR	INR	NN	I-NP	B-protein
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
dosing	dosing	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
S	S	NNP	B-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Anticoagulation	Anticoagulation	NNP	I-NP	O
Service	Service	NNP	I-NP	O
at	at	IN	B-PP	O
915-360-5305	915-360-5305	CD	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-6253548	5-6253548	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
GOODNOE	GOODNOE	NNP	B-NP	O
,	,	,	O	O
IAN	IAN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LEDLOW	LEDLOW	NNP	B-NP	O
,	,	,	O	O
JEROMY	JEROMY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
4160521	4160521	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/16/07	1/16/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/16/07	1/16/07	CD	B-NP	O

